|
401
|
|
|
Ankyrin 2 |
ANK-2, CFAP87, FAP87, LQT4, brank-2 |
Arrhythmogenic right ventricular cardiomyopathy, Atrial fibrillation, Autism, Brugada syndrome, Cardiac arrest, Cardiac arrhythmia, Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia, Cerebrovascular disorder, Neurodevelopmental disorder, Congenital cardiovascular anomaly, Crohn disease, Long qt syndrome, Heart disease, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intellectual developmental disorder, Meniere disease, Neurodevelopmental disorders, Non-specific syndromic intellectual disability, Peripheral vascular disease, Polymorphic catecholaminergic ventricular tachycardia, Preeclampsia , Schizophrenia, Scoliosis, Sick sinus syndrome, Stroke, Venous thromboembolism, Wolff-parkinson-white syndromeView all (14 more) |
|
402
|
|
|
Ankyrin 3 |
ANKYRIN-G, MRT37 |
Alzheimer disease, Anhedonia, Atrial fibrillation, Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Central nervous system cancer, Congenital neurologic anomalies , Dementia, Bipolar depression, Tourette syndrome, Glioblastoma, Glioma, Intellectual developmental disorder, Intellectual developmental disorder hypotonia spastic sleep, Lung neoplasms, Major depressive disorder, Metabolic syndrome, Mood disorder, Non-organic psychosis, Non-specific syndromic intellectual disability, Oligodendroglioma, Post-traumatic stress disorder, Prion disease, Prostate cancer, Psychotic disorders, Schizophrenia, Scoliosis, Amyotrophic lateral sclerosis, Status epilepticus, Diabetes mellitus, type 2, Ulcerative colitis, Venous thromboembolismView all (18 more) |
|
403
|
|
|
Adipogenesis associated Mth938 domain containing |
C11orf67, CK067, PTD015 |
|
|
404
|
|
|
Acyl-CoA dehydrogenase family member 9 |
MC1DN20, NPD002 |
|
|
405
|
|
|
ABR activator of RhoGEF and GTPase |
MDB |
|
|
406
|
|
|
Alanyl aminopeptidase, membrane |
AP-M, AP-N, APN, CD13, GP150, LAP1, P150, PEPN, hAPN |
|
|
407
|
|
|
Rho GTPase activating protein 35 |
GRF-1, GRLF1, P190-A, P190A, p190ARhoGAP, p190RhoGAP |
|
|
408
|
|
|
Ankyrin repeat domain containing 11 |
ANCO-1, ANCO1, LZ16, T13 |
16q24.3 microdeletion syndrome, Alzheimer disease, Asthma, Astigmatism, Autism, Basal cell carcinoma, Biliary tract cancer, Bipolar disorder, Blepharoptosis, Bone disease, Breast cancer, Cancer, Cervical cancer, Colorectal cancer, Congenital heart disease, Congenital neurologic anomalies , Cryptorchidism, Melanoma, Desbuquois syndrome, Developmental disability, Endometrial cancer, Epilepsy, Esophageal cancer, Esotropia, Estrogen-receptor negative breast cancer, Gastric cancer, Global developmental delay, Hepatocellular carcinoma, Hyperopia, Intellectual developmental disorder, Keratinocyte carcinoma, Lung cancer, Metabolic bone disorder, Metabolic syndrome, Multiple myeloma, Neurodevelopmental disorders, Non-hodgkins lymphoma, Non-melanoma skin carcinoma, Non-small cell lung carcinoma, Ovarian cancer, Ovarian serous carcinoma, Pancreatic cancer, Prostate cancer, Squamous cell carcinoma, Diabetes mellitus, type 2View all (30 more) |
|
409
|
|
|
Activator of basal transcription 1 |
Esf2, hABT1 |
Alzheimer disease, Anorexia nervosa, Cannabis abuse, Dental caries, Inflammatory bowel disease, Irritable bowel syndrome, Lung cancer, Major depressive disorder, Multiple sclerosis, Obesity, Obsessive-compulsive disorder, Post-traumatic stress disorder, Psoriasis, Rheumatoid arthritis, Schizophrenia, Small cell lung carcinoma, Squamous cell carcinoma, Stomach neoplasms, Upper aerodigestive tract neoplasmView all (4 more) |
|
410
|
|
|
ALG6 alpha-1,3-glucosyltransferase |
CDG1C |
|
